Reference is made to the stock exchange announcement made on 6 June 2023 regarding Nordic Nanoctor ASA's ("Nordic c Nanovector") contemplated acquisition of all the issued and outstanding shares in Thor Medical AS (the "Transaction"), and the stock exchange announcement on 28 June regarding the approval of the Transaction by the Company's annual general meeting. Additionally, Brede Ellingsæter has assumed the position as CFO of the Company.